Santhera Pharmaceuticals Holding's total assets for Q2 2024 were CHF108.25M, a decrease of -1.26% from the previous quarter. CH:SANN total liabilities were CHF60.19M for the fiscal quarter, a 21.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.